Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 3 | 2020 | 15 | 1.900 |
Why?
|
| RNA, Long Noncoding | 2 | 2020 | 14 | 1.270 |
Why?
|
| Vitamin D | 2 | 2020 | 4 | 1.170 |
Why?
|
| Exosomes | 2 | 2024 | 5 | 1.010 |
Why?
|
| Extracellular Vesicles | 2 | 2024 | 8 | 0.980 |
Why?
|
| Neoplasms | 3 | 2024 | 99 | 0.980 |
Why?
|
| p21-Activated Kinases | 1 | 2024 | 1 | 0.910 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 12 | 0.900 |
Why?
|
| Cell Proliferation | 5 | 2024 | 120 | 0.730 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2021 | 3 | 0.730 |
Why?
|
| Colonic Neoplasms | 2 | 2021 | 5 | 0.690 |
Why?
|
| Histone Deacetylase 1 | 1 | 2020 | 2 | 0.680 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2020 | 6 | 0.680 |
Why?
|
| Drug Carriers | 1 | 2020 | 9 | 0.680 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 9 | 0.680 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 30 | 0.660 |
Why?
|
| Indoles | 1 | 2020 | 8 | 0.660 |
Why?
|
| Gold | 1 | 2020 | 49 | 0.660 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 13 | 0.640 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2020 | 26 | 0.630 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 19 | 0.630 |
Why?
|
| Humans | 13 | 2024 | 5477 | 0.630 |
Why?
|
| RNA | 1 | 2019 | 30 | 0.620 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 175 | 0.580 |
Why?
|
| Apoptosis | 3 | 2024 | 55 | 0.540 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 31 | 0.500 |
Why?
|
| Animals | 5 | 2024 | 1817 | 0.420 |
Why?
|
| Cell Movement | 3 | 2024 | 64 | 0.410 |
Why?
|
| Cell Cycle | 2 | 2020 | 11 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 55 | 0.320 |
Why?
|
| Acetylation | 2 | 2020 | 7 | 0.300 |
Why?
|
| Histones | 2 | 2020 | 13 | 0.300 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 35 | 0.290 |
Why?
|
| MicroRNAs | 2 | 2019 | 55 | 0.270 |
Why?
|
| Endosomes | 2 | 2024 | 2 | 0.250 |
Why?
|
| Drug Delivery Systems | 2 | 2024 | 28 | 0.240 |
Why?
|
| Pharmaceutical Preparations | 1 | 2024 | 12 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 30 | 0.200 |
Why?
|
| Transcription Factors | 2 | 2021 | 69 | 0.200 |
Why?
|
| Peptidomimetics | 1 | 2021 | 2 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 6 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2021 | 6 | 0.180 |
Why?
|
| Virus Internalization | 1 | 2021 | 7 | 0.180 |
Why?
|
| Peptoids | 1 | 2021 | 5 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 27 | 0.180 |
Why?
|
| Gene Editing | 1 | 2020 | 1 | 0.170 |
Why?
|
| Piperazines | 1 | 2020 | 1 | 0.170 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2020 | 6 | 0.170 |
Why?
|
| Imidazoles | 1 | 2020 | 15 | 0.170 |
Why?
|
| Genes, myc | 1 | 2020 | 1 | 0.160 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2020 | 1 | 0.160 |
Why?
|
| Calcitriol | 1 | 2020 | 3 | 0.160 |
Why?
|
| Oncogenes | 1 | 2020 | 5 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 3 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 72 | 0.160 |
Why?
|
| Molecular Docking Simulation | 1 | 2020 | 30 | 0.160 |
Why?
|
| Wound Healing | 1 | 2020 | 15 | 0.160 |
Why?
|
| Gene Expression | 1 | 2020 | 52 | 0.160 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 6 | 0.160 |
Why?
|
| Folic Acid | 1 | 2019 | 4 | 0.160 |
Why?
|
| Cytosol | 1 | 2019 | 7 | 0.160 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 23 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 17 | 0.160 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 35 | 0.160 |
Why?
|
| RNA, Messenger | 1 | 2019 | 69 | 0.150 |
Why?
|
| Treatment Outcome | 1 | 2019 | 212 | 0.150 |
Why?
|
| RNAi Therapeutics | 1 | 2017 | 1 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 21 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2017 | 74 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2017 | 30 | 0.130 |
Why?
|
| Female | 2 | 2020 | 2811 | 0.110 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 14 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 11 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 17 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 44 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 53 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 85 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 3 | 0.040 |
Why?
|
| Protein Binding | 1 | 2021 | 118 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2021 | 9 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 137 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 7 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 24 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2017 | 6 | 0.030 |
Why?
|
| Aptamers, Nucleotide | 1 | 2017 | 17 | 0.030 |
Why?
|
| Mice | 1 | 2017 | 719 | 0.030 |
Why?
|
| Male | 1 | 2017 | 2765 | 0.020 |
Why?
|